Multiple Sclerosis: Oligopeptide Research Reference
Chronic autoimmune demyelinating disease of the central nervous system. Relapsing-remitting (85% initially), secondary progressive, primary progressive. Path...
Overview
Chronic autoimmune demyelinating disease of the central nervous system. Relapsing-remitting (85% initially), secondary progressive, primary progressive. Path…tion, axonal loss, gliosis. MRI: white matter lesions (plaques). Clinical: optic neuritis, transverse myelitis, cerebellar ataxia. Treatments: interferons (IFN-β1a, IFN-β1b), glatiramer acetate, natalizumab, ocrelizumab, fingolimod, dimethyl fumarate, teriflunomide, cladribine.
Clinical Significance
This molecule has important therapeutic or diagnostic applications in clinical medicine.
References
- Encyclopeptide Database. “Multiple Sclerosis” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Multiple Sclerosis: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept